Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer

NCT02138383 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Enzalutamide
DRUG: Gemcitabine
DRUG: Nab-paclitaxel

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]